Laurus Labs

Key Milestones

Key Milestones

Incorporated as a private limited company in 2005, Laurus Labs set up its R&D center at Hyderabad with in one year. Year 2007 turned out to be a momentous year for Laurus Labs with not only the R & D center commencing operations, but also the initiation, completion and commissioning of the large-scale API manufacturing facility (Unit – I) at Visakhapatnam. After two years of focused R & D output resulting in multiple product launches and DMF filings, Laurus crossed yet another significant milestone when Unit – I received key regulatory approvals from USFDA, TGA and UK MHRA in 2010 our manufacturing facilities have also received one or more approvals from KFDA, PMDA, WHO, NIP Hungary and BfArM.

The key events in the history of our company includes.


calender icon
Arrow milestone2016
  • Successful US FDA inspection of the kilo lab facility at R&D Center, Hyderabad
  • Received approval from BfraM Germany for Unit 2 at Vishakhapatnam
  • Crossed INR 15 billion in revenues
  • Filed first ANDA with the US FDA and first dossier with the WHO
calender icon
Arrow milestone2015
  • Commenced commercial operations at Unit 3, Visakhapatnam
  • Acquired 27% stake in Sriam Labs Private Limited, Hyderabad
  • Successful inspection by WHO, NIP Hungary and US FDA for Unit 1 and Unit 3 manufacturing sites
calender icon
Arrow milestone2014
  • Purchased about approximately 135 acres of land at Visakhapatnam for future expansion
  • Investment of `3,000 million by Bluewater and acquisition by Bluewater of significant stake from FIL Capital Management and FIP (acting through FIL Capital Advisors) through secondary share purchase transaction
  • Commenced construction of Unit 2
  • Incorporated Laurus Inc. at Delaware as a wholly owned subsidiary of our Company
calender icon
Arrow milestone2013
  • Crossed INR.10 billion of revenues
  • Received WHO approval for Unit-I at Visakhapatnam
calender icon
Arrow milestone2012
  • Investment of INR. 490 million in our Company by FIL Capital Management and FIP through primary investment and secondary acquisition of Aptuit’s majority stake in the Company along with additional investments by one of our Promoters
calender icon
Arrow milestone2011
  • Received USFDA certification for the R&D Center, Hyderabad
  • Received Korean FDA certification for Unit 1, Vishakhapatnam and the R&D Centre, Hyderabad
calender icon
Arrow milestone2010
  • Received US FDA certification, TGA and UK MHRA certification for the Unit 1, Vishakhapatnam
  • Supplied our Company’s first product to the USA
calender icon
Arrow milestone2009
  • DSIR recognition received for the R&D Centre, Hyderabad
  • Commercialised four nutritional Fine Chemicals
  • Launched first product in Europe
  • Entered into a license agreement with an international organisation and a multinational company for license to manufacture and sell one of our products in the ARV segment
calender icon
Arrow milestone2008
  • Filed first ever Drug Master File
  • Commenced operations at Unit-I Visakhapatnam
  • Supplied company’s first product to USA
calender icon
Arrow milestone2007
  • Set up API manufacturing facility Unit-I at Visakhapatnam
  • Investment by Aptuit Singapore of `1.02 billion in our Company
  • Executed manufacturing and services agreements with three multinational companies
  • Commenced operations at R&D Centre
calender icon
Arrow milestone2006
  • Set up the R&D Centre at IKP, Knowledge Park, Hyderabad
  • Signed Term Sheet with a leading Indian pharmaceutical company for oncology APIs
  • Filed our first patent application
Top